3//SEC Filing
Polaris Partners VII, L.P. 3
Accession 0000950170-24-114172
CIK 0001736730other
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 9:34 PM ET
Size
13.6 KB
Accession
0000950170-24-114172
Insider Transaction Report
Form 3
Polaris Management Co. VII, L.L.C.
10% Owner
Holdings
- (indirect: See Footnote)
Series A Prime Preferred Stock
→ Common Stock (1,250,061 underlying) - (indirect: See Footnote)
Series A Prime Preferred Stock
→ Common Stock (87,448 underlying) - (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (353,718 underlying) - (indirect: See Footnote)
Series B Preferred Stock
→ Common Stock (24,745 underlying)
Footnotes (3)
- [F1]Each share of Series A Prime Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") is convertible into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a 11.2158-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Preferred Stock will convert automatically into shares of Common Stock of the Issuer. The Preferred Stock has no expiration date.
- [F2]The reported securities are owned directly by Polaris Partners VII, L.P. ("PP VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of PP VII. Each of David Barrett, Brian Chee, Amir Nashat, a member of the Issuer's board of directors, and Bryce Youngren (collectively, the "Managing Members") are the managing members of PMC VII. Each of PMC VII and the Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP VII. Each of PMC VII and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
- [F3]The reported securities are owned directly by Polaris Entrepreneurs' Fund VII, L.P. ("PEF VII"). PMC VII is the general partner of PEF VII. Each of PMC VII and the Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PEF VII. Each of PMC VII and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
Documents
Issuer
Camp4 Therapeutics Corp
CIK 0001736730
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001611189
Filing Metadata
- Form type
- 3
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 9:34 PM ET
- Size
- 13.6 KB